Prostate cancer screening faces barriers due to misinformation and stigma

Prostate cancer remains the most common cancer among men aged 50 and older in the United States, yet screening rates are hindered by misinformation, stigma, and socioeconomic barriers. Lorelei Mucci, a professor of epidemiology at the Harvard T. H. Chan School of Public Health, notes that many men hold outdated views of screening, unaware that it often involves a simple blood test rather than invasive procedures.

Key barriers to screening include lower engagement with healthcare among men compared to women, lower income, less education, and lack of insurance. Research suggests that social support from family and friends, as well as low-cost healthcare interventions like postcard reminders or digital messages, can improve engagement.

While prostate cancer is the second leading cause of cancer-related deaths in men, the five-year survival rate for stages 1 and 2 is nearly 99%. Other significant risks for men include lung cancer, which is the leading cause of cancer-related deaths, and colorectal cancer, which is the third most common. Early detection through regular screenings, such as colonoscopies, remains vital for improving survival outcomes.